Real‐world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome

BACKGROUND: Hepatorenal syndrome and acute kidney injury are common complications of decompensated cirrhosis, and terlipressin is recommended as first‐line vasoconstrictor therapy. However, data on its use outside of clinical trials are lacking. AIMS: To assess practice patterns and outcomes around...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Aliment Pharmacol Ther
Asıl Yazarlar: Moore, Kevin, Jamil, Khurram, Verleger, Katharina, Luo, Linlin, Kebede, Nehemiah, Heisen, Marieke, Corman, Shelby, Leonardi, Roberta, Bakker, Rachel, Maï, Christine, Shamseddine, Nisreen, Huang, Xingyue, Allegretti, Andrew S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Terlipressin in Hepatorenal Syndrome
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7383732/
https://ncbi.nlm.nih.gov/pubmed/32495956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.15836
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller